Showing results (231-240 of 655) with videos related to
Sort By:
Pageof 66
Journal of Managed Care Pharmacy : JMCP|May 1, 2013
One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent eventsShih-Yin Chen, Ning Wu, Michael Gulseth, et al.Journal of Managed Care Pharmacy : JMCP|May 1, 2013
Quality compensation programs: are they worth all the hype? A comparison of outcomes within a Medicare advantage heart failure populationTara Esse, Omar Serna, Abhishek Chitnis, et al.Journal of Managed Care Pharmacy : JMCP|April 11, 2013
New concepts in diabetes: how multihormonal regulation can improve glycemic controlLawrence Blonde, Danial E Baker, Stephen N Davis, et al.Journal of Managed Care Pharmacy : JMCP|April 11, 2013
Best practices in innovative type 2 diabetes program management: a case studyH Eric CannonJournal of Managed Care Pharmacy : JMCP|March 30, 2013
Impact of a patient-centered pharmacy program and intervention in a high-risk groupJanice M Moore, Deborah Shartle, Larry Faudskar, et al.Journal of Managed Care Pharmacy : JMCP|June 29, 2013
The effect of hepatitis C treatment response on medical costs: a longitudinal analysis in an integrated care settingM Michele Manos, Jeanne Darbinian, Jaime Rubin, et al.Journal of Managed Care Pharmacy : JMCP|June 29, 2013
Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patientsPooja R Desai, Kenneth A Lawson, Jamie C Barner, et al.Journal of Managed Care Pharmacy : JMCP|June 29, 2013
Influence of coadministration of antithrombotic medicines, warfarin, and NSAIDs on heparin safety: data from a prospective observational studyGabriele Pranckeviciene, Edmundas Kadusevicius, Asta PutnieneJournal of Managed Care Pharmacy : JMCP|November 23, 2005
Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical CentersTimothy A Mazzolini, Brian K Irons, Evans C Schell, et al.Journal of Managed Care Pharmacy : JMCP|January 5, 2010
Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organizationBrieana C Buckley, Derek Roylance, Matthew P Mitchell, et al.Pageof 66